The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
about
MDMA for the treatment of mood disorder: all talk no substance?Toxicity of amphetamines: an updateThe safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyLost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansThe norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humansThe pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to ratsEcstasy exposure & gender: examining components of verbal memory functioningEcstasy: are animal data consistent between species and can they translate to humans?Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesEffects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care.The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.Drug dependence: neuropharmacology and management.Preventing problems in Ecstasy users: reduce use to reduce harm.Acute psychological and neurophysiological effects of MDMA in humans.Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated ratsA review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers.Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteersPhysiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.Effects of MDMA on body temperature in humansPharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Serotonin and brain function: a tale of two receptorsInhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).Control of the Cutaneous Circulation by the Central Nervous System.MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei.MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.Key interindividual determinants in MDMA pharmacodynamics.Progress and promise for the MDMA drug development program.No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.Ecstasy use and self-reported disturbances in sleep.A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.Is the recreational use of 3,4-methylenedioxy-methamphetamine safe?
P2860
Q21558551-81187F2E-EE16-45E7-B8BE-82B0B6C4C327Q22252794-E9070855-7759-45E4-B30E-194861F784F0Q24606265-B38B4A4F-B470-49E7-8D14-A95F0A7E35EFQ26859367-3C91FC30-08CD-401C-A355-0342D1648ABCQ28240897-BBEFD371-B54C-4167-8DF7-1D6E7ACE6DF3Q28344876-3CD5B955-8728-4E65-9EFD-C096BD57E599Q28542888-9EA417E4-1D06-45B1-9649-F19588BA9670Q31033315-4A4AC194-DF8D-40BC-9E7E-78697AAE06D4Q34030711-F9C3573A-9A89-4D7A-B19A-903FCF99BC15Q34112933-62ED55C1-FCBD-44C7-B9D8-ED73BA056D50Q34391195-5F53ECA7-C54A-469F-AF9B-C6E23FC2514DQ34542261-5418261E-9A80-4754-B9FA-6E2545C5BEAAQ34565294-CE29D424-EE58-4EA1-BE54-B8E690AE15A2Q34647657-112FD1DA-1A59-4923-A69B-D9B6BC016236Q34773986-5E7A3BB7-4631-407D-B6A8-C7B941749E88Q35105557-9D34D055-386B-4DE0-8F5C-88D6C8C5A381Q35105559-3615422D-D3D0-4BDE-8391-9D2285574121Q35965775-7F585A97-66E7-46DB-9C91-720E26407B5CQ36410788-DCBD46F7-6C5A-47E4-A12E-BBADBD0E545DQ36502642-E1058C46-E4BE-49EF-82C1-3E2D4D1D7E36Q36983556-1E0348D7-7C49-47B4-B0EB-8B74D662EA3FQ37226598-A0962D17-5403-43BB-8A12-2F8835436133Q38048826-38B603EB-9D97-4803-AD4C-956D0759DDA0Q38600048-7C4765F2-E737-4F2D-8784-B16EEBF40B3DQ38652284-C6C6D62D-BF84-4139-AD3C-F10F76C18231Q38848104-23821CDB-733F-4883-AA24-CDA114ECDE3DQ40007746-BCEC71DA-B9C9-46A5-BED0-9B38A5E159D5Q41595301-DB14716B-A064-4E09-90D6-112A99EC3F59Q41669953-85C9BC87-6631-47E8-B49D-74A0BFB881C3Q43729285-59DAF0F3-0E8B-407A-A86B-7C0454696C01Q43842077-4C72E924-0B8D-4998-AD81-ECF7D34D2F56Q44959633-4E153822-8745-4C1C-957A-2E17322AA9B4Q46058170-A5BCBA63-7CCB-4596-9DF9-E6D623C364B5Q46150848-9C76FEA4-F64F-4F3B-A2C0-2E9420C052A2Q47206849-D63E52F1-44E7-4CD5-B5A1-AB85F49B7766Q47963200-D5E2D5D9-A979-43CF-AB66-A28CF1EFB491Q48190285-3524D826-7780-43CA-8FD3-64EFD130182AQ48281295-7F424617-0875-4FD4-9E17-6FD398A608A0Q48381656-EC519504-9F88-437C-863E-62DBBDFB5CC8Q50127081-7AD59B04-309D-4F1B-BBCE-02E0AAE99674
P2860
The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@en
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@nl
type
label
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@en
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@nl
prefLabel
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@en
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@nl
P2860
P1476
The serotonin uptake inhibitor ...... stasy') in healthy volunteers.
@en
P2093
F X Vollenweider
M E Liechti
P2860
P304
P356
10.1177/026988110001400313
P407
P577
2000-01-01T00:00:00Z